PT Lippo Karawaci Tbk (PTLKF)
OTCMKTS · Delayed Price · Currency is USD
0.0104
-0.0012 (-10.34%)
At close: Sep 23, 2025
PT Lippo Karawaci Tbk Revenue
PT Lippo Karawaci Tbk had revenue of 2.34T IDR in the quarter ending September 30, 2025, with 91.97% growth. This brings the company's revenue in the last twelve months to 8.56T, down -37.22% year-over-year. In the year 2024, PT Lippo Karawaci Tbk had annual revenue of 11.35T, down -32.06%.
Revenue (ttm)
8.56T IDR
Revenue Growth
-37.22%
P/S Ratio
0.82
Revenue / Employee
4.82B IDR
Employees
1,775
Market Cap
421.39M USD
Revenue Chart
* This company reports financials in IDR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.35T | -5,354.06B | -32.06% |
| Dec 31, 2023 | 16.70T | 2.03T | 13.82% |
| Dec 31, 2022 | 14.67T | -1,464.45B | -9.07% |
| Dec 31, 2021 | 16.14T | 4.33T | 36.64% |
| Dec 31, 2020 | 11.81T | -366.22B | -3.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veltex | 70.13M |
| Selectis Health | 42.17M |
| Mid-Atlantic Home Health Network | 27.00M |
| Cardiff Lexington | 11.88M |
| Stem Cell Authority | 3.33M |
| HealthLynked | 2.37M |
| BioCorRx | 948.36K |
PT Lippo Karawaci Tbk News
- 3 months ago - PT Lippo Karawaci Tbk (PTLKF) Q3 2025 Earnings Call Transcript - Seeking Alpha